Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Gains from Investment Securities (2019 - 2023)

Historic Gains from Investment Securities for China Pharma Holdings (CPHI) over the last 8 years, with Q4 2023 value amounting to $201865.0.

  • China Pharma Holdings' Gains from Investment Securities changed N/A to $201865.0 in Q4 2023 from the same period last year, while for Dec 2023 it was -$2124.0, marking a year-over-year change of. This contributed to the annual value of $156273.0 for FY2023, which is N/A changed from last year.
  • As of Q4 2023, China Pharma Holdings' Gains from Investment Securities stood at $201865.0.
  • China Pharma Holdings' 5-year Gains from Investment Securities high stood at $236055.0 for Q1 2019, and its period low was -$204518.0 during Q3 2023.
  • Moreover, its 3-year median value for Gains from Investment Securities was -$738.0 (2019), whereas its average is $28440.0.